Depression and anxiety in COPD

Depression and anxiety in COPD are regular in patients with chronic obstructive pulmonary disease (COPD), assessments of their pervasiveness differ significantly. These likely reflect the assortment of scales and strategies used to measure such symptoms. Patients with COPD with three or more comorbidities are more likely to be frequently hospitalized and may die prematurely compared to COPD patients without comorbidities.  An uplifted experience of dyspnoea is probably contributing component to anxiety. Feelings of depression may be precipitated by the loss and grief associated with the disability of COPD. Smoking has been associated with nicotine addiction, and the factors that contribute to smoking may also predispose to anxiety and depressive disorders. The cause of depression and anxiety symptoms are multifactorial and include behavioural, social and biological factorsLung Conferences exhibits randomized controlled trials show that activity exercise training and precisely chose pharmacological treatment are regularly effective in ameliorating anxiety and depression.

  • Prevalence in COPD
  • Classification and diagnostic criteria
  • Clinical features and impact
  • Screening and diagnosis
  • Risk factors
  • Mechanism of potential association with COPD

Related Conference of Depression and anxiety in COPD

August 17-18, 2020

10th International Conference on COPD and Lungs

Prague, Czech Republic
October 19-20, 2020

International Congress and Expo on Pulmonology

Manila, Philippines
October 29-30, 2020

International Conference on Lung Diseases

Cape Town, South Africa
November 18-19, 2020

International Conference on Asthma and Allergy

Lisbon, Portugal
December 07-08, 2020

8th Annual Congress on Pulmonary and Critical Care

Tokyo, Japan

Depression and anxiety in COPD Conference Speakers

Recommended Sessions

Related Journals

Are you interested in